Literature DB >> 342317

A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.

A Hrabar, I Vodopija, F E André, J R Mitchell, H F Maassab, A V Hennessy, F M Davenport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 342317

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


× No keyword cloud information.
  11 in total

1.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Characterization of the temperature sensitive phenotype of the A/Ann Arbor/6/60 cold-adapted virus and its recombinants.

Authors:  B R Murphy; H F Maassab; F T Wood; R M Chanock
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

Review 3.  Vaccines for preventing influenza in healthy children.

Authors:  Tom Jefferson; Alessandro Rivetti; Carlo Di Pietrantonj; Vittorio Demicheli; Eliana Ferroni
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.

Authors:  B R Murphy; R M Chanock; M L Clements; W C Anthony; A J Sear; L A Cisneros; M B Rennels; E H Miller; R E Black; M M Levine; R F Betts; R G Douglas; H F Maassab; N J Cox; A P Kendal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Infant rat model of attenuation for recombinant influenza viruses prepared from cold-adapted attenuated A/Ann Arbor/6/60.

Authors:  M Ali; H F Maassab; R Jennings; C W Potter
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.

Authors:  T R Cate; R B Couch
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

8.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

Authors:  B R Murphy; M B Rennels; R G Douglas; R F Betts; R B Couch; T R Cate; R M Chanock; A P Kendal; H F Maassab; S Suwanagool; S B Sotman; L A Cisneros; W C Anthony; D R Nalin; M M Levine
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

Review 10.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.